Trial Profile
Phase I trial of CRLX 288 [docetaxel] for the treatment of solid tumours
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 16 Nov 2010
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 16 Nov 2010 New trial record